Chronic liver diseases such as hepatitis, liver cirrhosis, and hepatocellular carcinoma are a major cause of morbidity and mortality worldwide. Fibrosis—the thickening and scarring of connective ...

Please provide your email address to receive an email when new articles are posted on . Treatment responders demonstrated significant reductions in iron corrected T1 and liver fat content. Optimal ...

WASHINGTON & OXFORD, England--(BUSINESS WIRE)--Perspectum announced two research studies that were recently published, bringing hope to people with metabolic dysfunction-associated steatohepatitis ...

Non-contrast MRI as a surveillance tool for recurrent hepatocellular carcinoma after curative treatment: A prospective multicenter intra-individual comparison trial. First line atezolizumab + ...

Quibim, a global company pioneering imaging biomarkers for precision medicine, is today announcing the launch of a new product, QP-Liver, which improves the diagnosis of diffuse liver diseases through ...

Dr. Jason Chiang and Dr. Kyung Sung of the department of radiological sciences at the David Geffen School of Medicine at UCLA and the UCLA Health Jonsson Comprehensive Cancer Center have received a $3 ...

The Korea Research Institute of Standards and Science (KRISS) has developed the world’s first reference material to improve the accuracy of body fat measurements conducted through MRI and CT scans.

CHICAGO--(BUSINESS WIRE)--Contrast-enhanced ultrasound (CEUS) is more accurate and reliable than MRI for examining certain liver and kidney nodules, according to two new studies published in the ...

While current imaging and diagnosis of HCC primarily depend on contrast-enhanced CT or MRI to identify structural changes, PET imaging has the potential to reveal early molecular alterations that ...

After 30 years in medicine, Dr Nguyen Quang Thai Duong has become one of the pioneers of minimally invasive intervention in ...